基因表現分析市場規模、佔有率、成長分析（按產品、流程、數量、方法、應用和地區）- 產業預測，2025 年至 2032 年

2023 年全球基因表現分析市場規模價值 48 億美元，預計將從 2024 年的 52 億美元成長到 2032 年的 99.2 億美元，預測期間（2025-2032 年）的複合年成長率為 8.4%。

受個人化醫療和精準治療需求不斷成長的推動，全球基因表現分析市場預計將顯著成長。該市場使臨床醫生能夠識別與特定疾病相關的獨特基因特徵，從而促進標靶治療。次世代定序儀(NGS) 和微陣列技術的進步使得分析更加高效、更具成本效益，使研究人員能夠管理大量資料並揭示關鍵的基因調控網路。癌症和心血管疾病等慢性疾病的發生率不斷上升，推動了生物標記發現和治療開發中對基因表現分析的需求。然而，需要解決諸如複雜的資料解釋、熟練的生物資訊學專業人員短缺以及使用該技術的高成本挑戰，以最佳化市場潛力並確保其在各個環境中的廣泛應用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

基因表現分析市場規模（按產品）

• 市場概況
• 試劑和耗材
  • 檢測和套件
  • 酵素
  • DNA晶片
  • 其他
• 裝置
  • PCR
  • 次世代定序
  • DNA 微陣列
  • 其他
• 服務

基因表現分析市場規模（依流程）

• 市場概況
• 樣本採集
• 精製
• cDNA 合成與轉化
• PCR 分析
• 資料分析與解釋
• 其他

基因表現分析市場規模（按容量）

• 市場概況
• 低至中等複雜度
• 高複合

基因表現分析市場規模（依方法）

• 市場概況
• RNA表達
• 啟動子分析
• 蛋白質表現與轉譯後修飾分析

基因表現分析市場規模（按應用）

• 市場概況
• 藥物研發
• 臨床診斷
• 生物技術和微生物學
• 其他

基因表現分析市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Illumina（USA）
• Thermo Fisher Scientific（USA）
• Bio-Rad Laboratories（USA）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Pacific Biosciences of California（USA）
• BGI（China）
• PerkinElmer Inc.（USA）
• Agilent Technologies（USA）
• Quest Diagnostics（USA）
• Promega Corporation（USA）
• Luminex Corporation（USA）
• Takara Bio（Japan）
• Danaher Corporation（USA）
• Merck Sharp & Dohme Corp.（USA）
• Genotypic Technology Pvt Ltd（India）
• Macrogen（South Korea）
• Eurofins Scientific（Luxembourg）
• SciGenom Labs Pvt. Ltd（India）
• Takara Holdings（Japan）

結論和建議

Global Gene Expression Analysis Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.2 billion in 2024 to USD 9.92 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global gene expression analysis market is poised for significant growth, fueled by the rising demand for personalized medicine and precision therapies. This market enables clinicians to identify unique gene signatures linked to specific diseases, thereby facilitating targeted treatments. Advances in next-generation sequencing (NGS) and microarray technologies have made analysis more efficient and cost-effective, allowing researchers to manage extensive datasets and uncover key gene regulatory networks. The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, heightens the need for gene expression analysis in biomarker discovery and therapeutic development. However, challenges like complex data interpretation, a shortage of skilled bioinformatics professionals, and the high costs of technology utilization must be addressed to optimize market potential and ensure broader adoption across settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Expression Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Expression Analysis Market Segmental Analysis

Global Gene Expression Analysis Market is segmented by Product, Process, Capacity, Technique, Application and region. Based on Product, the market is segmented into Reagents & Consumables, Instruments and Service. Based on Process, the market is segmented into Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation and Others. Based on Capacity, the market is segmented into Low- to Mid- Plex and High-Plex. Based on Technique, the market is segmented into RNA Expression, Promoter Analysis and Protein Expression & Posttranslational Modification Analysis. Based on Application, the market is segmented into Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market is significantly propelled by the escalating incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders. This trend underscores the necessity of gene expression analysis as it facilitates a deeper understanding of the molecular mechanisms associated with these conditions. Such insights are essential for enabling early diagnosis, enhancing treatment strategies, and advancing drug discovery efforts. Consequently, the growing need for innovative diagnostic and therapeutic solutions to combat these widespread health challenges is fostering a robust demand for gene expression analysis technologies in the market, ultimately driving its expansion and evolution.

Restraints in the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market faces several restraints, primarily stemming from ethical and regulatory challenges. Concerns regarding the ethical use of genomic data, along with stringent regulations surrounding data privacy and protection, can hinder market growth. Adhering to data privacy laws, obtaining informed consent, and aligning research practices with ethical standards for managing patient information present significant obstacles for both researchers and companies in the gene expression analysis sector. As a result, the complexities associated with compliance may slow innovation and implementation within the market, ultimately impacting its overall development and expansion.

Market Trends of the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market is increasingly dominated by the trend of single-cell gene expression analysis, driven by advancements in microfluidics, isolation methods, and sequencing technologies. This innovative approach empowers researchers to delve into cellular heterogeneity, identify rare cell populations, and observe dynamic gene expression changes at the individual cell level. This granular understanding is crucial for applications across developmental biology, cancer research, and precision medicine, enhancing drug discovery and therapeutic strategies. As the demand for more precise genetic insights continues to grow, the single-cell analysis segment is poised to significantly influence the market landscape in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Gene Expression Analysis Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Consumables
  • Assays & kits
  • Enzymes
  • DNA chips
  • Others
• Instruments
  • PCR
  • NGS
  • DNA Microarrays
  • Others
• Service

Global Gene Expression Analysis Market Size by Process & CAGR (2025-2032)

• Market Overview
• Sample Collection
• Purification
• cDNA synthesis & conversion
• PCR Analysis
• Data analysis & interpretation
• Others

Global Gene Expression Analysis Market Size by Capacity & CAGR (2025-2032)

• Market Overview
• Low- to Mid- Plex
• High-Plex

Global Gene Expression Analysis Market Size by Technique & CAGR (2025-2032)

• Market Overview
• RNA Expression
• Promoter Analysis
• Protein Expression & Posttranslational Modification Analysis

Global Gene Expression Analysis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Clinical Diagnostics
• Biotech & Microbiology
• Others

Global Gene Expression Analysis Market Size & CAGR (2025-2032)

• North America (Product, Process, Capacity, Technique, Application)
  • US
  • Canada
• Europe (Product, Process, Capacity, Technique, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Process, Capacity, Technique, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Process, Capacity, Technique, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Process, Capacity, Technique, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Sharp & Dohme Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genotypic Technology Pvt Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SciGenom Labs Pvt. Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations